Carvedilol Patent Expiration
Carvedilol is Used for reducing mortality associated with congestive heart failure. It was first introduced by Waylis Therapeutics Llc
Carvedilol Patents
Given below is the list of patents protecting Carvedilol, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Coreg |
USRE40000 (Pediatric) | Method of treatment for decreasing mortality resulting from congestive heart failure |
Dec 07, 2015
(Expired) | Waylis Therap |
| Coreg | USRE40000 | Method of treatment for decreasing mortality resulting from congestive heart failure |
Jun 07, 2015
(Expired) | Waylis Therap |
Carvedilol's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List